Ann: Correction to Positive Metallurgical Results from Oposura, page-5

AZS raises are never value accretive, which is why the company needs to constantly offer better and better terms to sophs and financiers, eg lowball prices and options etc

This is why I refused to hold leading up to the most recent raise. The big price correction was a sure thing.

I agree the market in general seems leery of Tony. These sort of reputations once earned are hard to shake. I wouldn’t oppose bringing in a new MD to rebuild market confidence